Alpha 2.0
Login Register
» Articles » PMID: 35150458

Novel Statistics Predict the COVID-19 Pandemic Could Terminate in 2022

Overview
Journal J Med Virol
Specialty Microbiology
Date 2022 Feb 12
PMID 35150458
Authors
Ji-Ming Chen
Affiliations
Soon will be listed here.
Abstract

Many people want to know when the COVID-19 pandemic will end and life will return to normal. This question is highly elusive and distinct predictions have been proposed. In this study, the global mortality and case fatality rate of COVID-19 were analyzed using nonlinear regression. The analysis showed that the COVID-19 pandemic could terminate in 2022, but COVID-19 could be one or two times more deadly than seasonal influenza by 2023. The prediction considered the possibility of the emergence of new variants of SARS-CoV-2 and was supported by the features of the Omicron variant and other facts. As the herd immunity against COVID-19 established through natural infections and mass vaccination is distinct among countries, COVID-19 could be more or less deadly in some countries in the coming years than the prediction. Although the future of COVID-19 will have multiple possibilities, this statistics-based prediction could aid to make proper decisions and establish an example on the prediction of infectious diseases.

Citing Articles

A newly developed high-performance thin layer chromatographic method for determination of remdesivir, favipiravir and dexamethasone, in spiked human plasma: comparison with the published methods.

Abdelfatah R, Abdelmomen E, Abdelaleem E, Abdelmoety R, Emam A BMC Chem. 2025; 19(1):7.

PMID: 39773302 PMC: 11705924. DOI: 10.1186/s13065-024-01366-1.

The association between enteral nutrition with survival of critical patients with COVID-19.

Gholamalizadeh M, Salimi Z, Mobarakeh K, Mahmoudi Z, Tajadod S, Mousavi Mele M Immun Inflamm Dis. 2024; 12(5):e1261.

PMID: 38717056 PMC: 11078021. DOI: 10.1002/iid3.1261.

Equilibrium points and their stability of COVID-19 in US.

Hu X, Hu Z, Xu T, Zhang K, Lu H, Zhao J Sci Rep. 2024; 14(1):1628.

PMID: 38238368 PMC: 10796349. DOI: 10.1038/s41598-024-51729-w.

Thyroid Eye Disease as Initial Manifestation of Graves' Disease Following Viral Vector SARS-CoV-2 Vaccine: Report of a Case and Review of the Literature.

Armeni A, Markantes G, Stathopoulou A, Saltiki K, Zampakis P, Assimakopoulos S Vaccines (Basel). 2023; 11(10).

PMID: 37896977 PMC: 10611184. DOI: 10.3390/vaccines11101574.

COVID-19 vaccine acceptance among pregnant women: a hospital-based cross-sectional study in Sudan.

Omar S, Osman O, Khalil R, Al-Wutayd O, Adam I Front Public Health. 2023; 11:1221788.

PMID: 37529434 PMC: 10387537. DOI: 10.3389/fpubh.2023.1221788.

References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View
2.
Chen J, Chen Y, Sun Y . Control of COVID-19 in China likely reduced the burden of multiple other infectious diseases. J Infect. 2022; 84(4):579-613. PMC: 8743852. DOI: 10.1016/j.jinf.2022.01.001. View
3.
Rolfes M, Foppa I, Garg S, Flannery B, Brammer L, Singleton J . Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza Other Respir Viruses. 2018; 12(1):132-137. PMC: 5818346. DOI: 10.1111/irv.12486. View
4.
Chen J, Sun Y, Chen J . Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination. J Med Virol. 2020; 92(11):2453-2457. PMC: 7300630. DOI: 10.1002/jmv.26162. View
5.
Malki Z, Atlam E, Ewis A, Dagnew G, Ghoneim O, Mohamed A . The COVID-19 pandemic: prediction study based on machine learning models. Environ Sci Pollut Res Int. 2021; 28(30):40496-40506. PMC: 8035887. DOI: 10.1007/s11356-021-13824-7. View